WHO ICTRP trial
An open-label extension study of CACZ885H2356E1 on the treatment and prevention…
EUCTR2010-019559-23-LT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019559-23-LT |
|---|---|
| Public title | An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2 |
| Scientific title | An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2 |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;Colombia;Switzerland;Singapore;Latvia;Sweden;Lithuania;Australia;Russian Federation;Canada;Ukraine;Guatemala;Peru;Mexico;Belgium;Estonia |
| Conditions | Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective MedDRA version: 13.1 Level: PT Classification code 10018627 Term: Gout System… |
| Interventions | Trade Name: ILARIS Product Name: Canakinumab Product Code: ACZ885 Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: CANAKINUMAB CAS Number: 914613-48-2 Current Sponsor code: ACZ885 Concentration unit: mg… |
| Registration date | Apr 23, 2010 |
| Target size | 200 |
| Secondary IDs | CACZ885H2356E2 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: